MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury

Christian U Oeing1,2, Seungho Jun2, Sumita Mishra2

  • 1Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany, and German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany (C.U.O.).

Circulation Research
|January 6, 2021
PubMed
Abstract

Insights

Reduced TSC2 phosphorylation protects the heart from ischemia reperfusion injury by boosting mTORC1 activity and favoring glucose metabolism. This mechanism is crucial for ischemic preconditioning and myocardial protection.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Regulation
  • Cell Signaling

Background:

  • The mechanistic target of rapamycin complex-1 (mTORC1) pathway is activated by ischemia reperfusion (IR) injury and ischemic preconditioning (IPC).
  • The role of mTORC1 activation in IR injury remains controversial, with limited understanding of its metabolic impact.
  • Prior studies used broad mTORC1 modulation, hindering specific mechanistic insights.

Purpose of the Study:

  • To investigate the hypothesis that reduced TSC2 S1365 phosphorylation protects the myocardium against IR injury.
  • To determine if this reduction is essential for IPC by enhancing mTORC1 activity and promoting glycolytic metabolism.

Main Methods:

  • Utilized mice with S1365A (TSC2SA; phospho-null) and S1365E (TSC2SE; phosphomimetic) knockin mutations.
  • Assessed ex vivo and in vivo heart function, mTORC1 activation, and metabolic profiles following IR.
  • Manipulated perfusate glucose and fatty acid levels to evaluate substrate utilization.

Main Results:

  • TSC2SA hearts exhibited amplified mTORC1 activation and improved function post-IR compared to wild-type and TSC2SE hearts.
  • The protective effect in TSC2SA mice mimicked IPC, which also required reduced TSC2 S1365 phosphorylation.
  • Metabolically, TSC2SA hearts showed increased mitochondrial respiration and glycolytic capacity, with altered substrate utilization favoring glycolysis over fatty acid oxidation.

Conclusions:

  • TSC2-S1365 phosphorylation status critically regulates myocardial substrate utilization during IR.
  • Declined TSC2-S1365 phosphorylation activates mTORC1, shifting metabolism towards glycolysis for IR protection.
  • This pathway and reduced TSC2 S1365 phosphorylation are necessary for effective IPC.